Emmanuelle Girodon

3.6k total citations
73 papers, 1.4k citations indexed

About

Emmanuelle Girodon is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Genetics. According to data from OpenAlex, Emmanuelle Girodon has authored 73 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Pulmonary and Respiratory Medicine, 14 papers in Genetics and 13 papers in Genetics. Recurrent topics in Emmanuelle Girodon's work include Cystic Fibrosis Research Advances (51 papers), Neonatal Respiratory Health Research (26 papers) and Tracheal and airway disorders (19 papers). Emmanuelle Girodon is often cited by papers focused on Cystic Fibrosis Research Advances (51 papers), Neonatal Respiratory Health Research (26 papers) and Tracheal and airway disorders (19 papers). Emmanuelle Girodon collaborates with scholars based in France, Italy and Belgium. Emmanuelle Girodon's co-authors include Michel Goossens, Bruno Costes, Pascale Fanen, Nada Ghanem, Josiane Martin, Claude Férec, François Plassa, Thierry Bienvenu, Michel Vidaud and Alexandre Hinzpeter and has published in prestigious journals such as PLoS ONE, Human Molecular Genetics and Journal of Hepatology.

In The Last Decade

Emmanuelle Girodon

69 papers receiving 1.4k citations

Peers

Countries citing papers authored by Emmanuelle Girodon

Since Specialization

Citations

This map shows the geographic impact of Emmanuelle Girodon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuelle Girodon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuelle Girodon more than expected).

Fields of papers citing papers by Emmanuelle Girodon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuelle Girodon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuelle Girodon. The network helps show where Emmanuelle Girodon may publish in the future.

Co-authorship network of co-authors of Emmanuelle Girodon

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuelle Girodon. A scholar is included among the top collaborators of Emmanuelle Girodon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuelle Girodon. Emmanuelle Girodon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	WS15.03Elevated sweat chloride concentrations in people with cystic fibrosis with at least one N1303K, 2789+5G>A or R334W treated with elexacaftor/tezacaftor/ivacaftor 2025 ·Journal of Cystic Fibrosis ·Pierre‐Régis Burgel, (unknown), (unknown), Emmanuelle Girodon, Jean-Louis Paillasseur	0
2	Preliminary proposals for the follow-up of infants born to mothers with cystic fibrosis treated with CFTR modulators during the first two years of life 2025 ·Archives de Pédiatrie ·Philippe Reix, (unknown), Emmanuelle Girodon, Isabelle Sermet‐Gaudelus, Sophie Gautier	1
3	Putting bicarbonate on the spot: pharmacological insights for CFTR correction in the airway epithelium 2023 ·Frontiers in Pharmacology ·(unknown), (unknown), Elise Dréano, B. Chevalier, Aurélie Hatton, Mairead Kelly, (unknown), Gabrielle Planelles, Aleksander Edelman, Emmanuelle Girodon, Alexandre Hinzpeter, Gilles Crambert, Iwona Pranke, Luis J. V. Galietta, Isabelle Sermet‐Gaudelus	2
4	The French Compassionate Program of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with advanced lung disease and no F508delCFTRvariant 2023 ·European Respiratory Journal ·Pierre‐Régis Burgel, Isabelle Sermet‐Gaudelus, I. Durieu, Reem Kanaan, Julie Macey, Dominique Grenet, Michele Porzio, (unknown), R. Chiron, Christophe Marguet, Benoît Douvry, Nadine Dufeu, Isabelle Danner‐Boucher, P. Foucaud, Lydie Lemonnier, Emmanuelle Girodon, Jennifer Da Silva, Clémence Martin	42
5	Genetics of complex and syndromic palmoplantar keratoderma 2021 ·Annales de biologie clinique ·(unknown), (unknown), Emmanuelle Girodon, G. Hickman, E. Bourrat, Thierry Bienvenu	0
6	Penetrance is a critical parameter for assessing the disease liability of CFTR variants 2020 ·Journal of Cystic Fibrosis ·(unknown), M.‐P. Audrézet, Caroline Raynal, Isabelle Sermet‐Gaudelus, Thierry Bienvenu, Claude Férec, Anne Bergougnoux, (unknown), Virginie Scotet, À. Munck, Emmanuelle Girodon	11
7	Exon identity influences splicing induced by exonic variants and in silico prediction efficacy 2020 ·Journal of Cystic Fibrosis ·Natacha Martin, Anne Bergougnoux, (unknown), B. Chevalier, (unknown), David Baux, Bruno Costes, Pascale Fanen, Caroline Raynal, Isabelle Sermet‐Gaudelus, Emmanuelle Girodon, Magali Taulan‐Cadars, Alexandre Hinzpeter	6
8	Clinical interpretation of SPINK1 and CTRC variants in pancreatitis 2020 ·Pancreatology ·Emmanuelle Girodon, Vinciane Rebours, Jian‐Min Chen, A. Pagin, Philippe Lévy, Claude Férec, Thierry Bienvenu	8
9	Factors influencing readthrough therapy for frequent cystic fibrosis premature termination codons 2018 ·ERJ Open Research ·Iwona Pranke, Laure Bidou, Natacha Martin, Sandra Blanchet, Aurélie Hatton, (unknown), (unknown), Bruno Costes, B. Chevalier, Danielle Tondelier, Emmanuelle Girodon, (unknown), Aleksander Edelman, Pascale Fanen, Olivier Namy, Isabelle Sermet‐Gaudelus, Alexandre Hinzpeter	36
10	The importance of functional tests to assess the effect of a new CFTR variant when genotype–phenotype correlation is not possible 2017 ·Clinical Case Reports ·Alexandre Hinzpeter, (unknown), Isabelle Callebaut, Cécile Zordan, Bruno Costes, Julie Guichoux, A. Iron, Didier Lacombe, Natacha Martin, Benoı̂t Arveiler, Pascale Fanen, Patricia Fergelot, Emmanuelle Girodon	4
11	Recommandations pour la prise en charge et le suivi des nourrissons pour lesquels un diagnostic de mucoviscidose n’a pu être conclu après dépistage néonatal 2017 ·Archives de Pédiatrie ·Isabelle Sermet‐Gaudelus, J. Brouard, M.‐P. Audrézet, (unknown), Laurence Weiss, Nathalie Wizla, (unknown), (unknown), Muriel Le Bourgeois, (unknown), (unknown), Thao Nguyen‐Khoa, Caroline Raynal, M. Roussey, Emmanuelle Girodon	2
12	p.Arg75Gln, a CFTR variant involved in the risk of CFTR-related disorders? 2014 ·Journal of Human Genetics ·(unknown), (unknown), (unknown), D. Hubert, Pierre‐Régis Burgel, Philippe Lévy, Emmanuelle Girodon, Thierry Bienvenu	9
13	Combined Computational-Experimental Analyses ofCFTRExon Strength Uncover Predictability of Exon-Skipping Level 2013 ·Human Mutation ·(unknown), Alix de Becdelièvre, Lisa Golmard, Christian Vasseur, Cathérine Costa, Asma Chaoui, Natacha Martin, Bruno Costes, Michel Goossens, Emmanuelle Girodon, Pascale Fanen, Alexandre Hinzpeter	25
14	Improvement of interpretation in cystic fibrosis clinical laboratory reports: longitudinal analysis of external quality assessment data 2012 ·European Journal of Human Genetics ·(unknown), Emmanuelle Girodon, Martin Schwarz, Manfred Stuhrmann, Michael A. Morris, Elisabeth Dequeker	7
15	Alternative Splicing of In-Frame Exon Associated with Premature Termination Codons: Implications for Readthrough Therapies 2012 ·Human Mutation ·Alexandre Hinzpeter, (unknown), Alix de Becdelièvre, Éric Bieth, Elvira Sondo, Natacha Martin, Bruno Costes, Cathérine Costa, Michel Goossens, Luis J. V. Galietta, Emmanuelle Girodon, Pascale Fanen	10
16	A recurrent deep-intronic splicing CF mutation emphasizes the importance of mRNA studies in clinical practice 2011 ·Journal of Cystic Fibrosis ·Cathérine Costa, V. Prulière‐Escabasse, Alix de Becdelièvre, (unknown), Lisa Golmard, Caroline Guittard, Laurence Bassinet, Thierry Bienvenu, Marie des Georges, Ralph Epaud, Éric Bieth, Irina Giurgea, (unknown), Alexandre Hinzpeter, Bruno Costes, Pascale Fanen, Michel Goossens, Mireille Claustres, A. Coste, Emmanuelle Girodon	17
17	Comprehensive Cystic Fibrosis Mutation Epidemiology and Haplotype Characterization in a Southern Italian Population 2005 ·Annals of Human Genetics ·Giuseppe Castaldo, Angela Polizzi, Rossella Tomaiuolo, C. Cazeneuve, Emmanuelle Girodon, Teresa Santostasi, Donatello Salvatore, Valeria Raia, N Rigillo, Michel Goossens, Francesco Salvatore	37
18	Identification of cystic fibrosis mutations in the United Arab Emirates 1998 ·Human Mutation ·Philippe M. Frossard, Emmanuelle Girodon, K. P. Dawson, Nada Ghanem, François Plassa, Gilles G. Lestringant, Michel Goossens	39
19	Exhaustive Scanning Approach to Screen All the Mitochondrial tRNA Genes for Mutations and Its Application to the Investigation of 35 Independent Patients with Mitochondrial Disorders 1998 ·Human Molecular Genetics ·Damien Sternberg, Claude Danan, A. Lombès, Pascal Laforêt, Emmanuelle Girodon, Michel Goossens, Serge Amselem	63
20	Rapid molecular characterization of mutations leading to unstable hemoglobin β-chain variants 1992 ·Annals of Hematology ·Emmanuelle Girodon, N. Ghanem, Michel Vidaud, J. Riou, Josiane Martin, Frédéric Galactéros, Michel Goossens	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact